News

Fresh out of high school, NC workers see $50,000-plus salaries at pharma giants
Wolfspeed bankruptcy watch, North Carolina lands more data centers, Duke University’s funding crunch, and an AI companion ...
Novo Nordisk Stock: Is It Still a Smart Buy?
I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...
STAT18h
A cautious culture cost Novo Nordisk its lead in the obesity drug race, former employees say
Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...
STAT18h
An AI experiment at the FDA & Novo trailing in the obesity drug race
This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...
360Dx1d
Randox Laboratories Gains FDA De Novo Clearance for Hemophilia CDx
The Randox ConcizuTrace ELISA is used to determine the concentration in blood of Novo Nordisk's Alhemo (concizumab-mtci) to aid dose adjustments.
Fierce Pharma1d
Novo Nordisk signs on to support ADA’s obesity advocacy division
Almost exactly a year after launching its Obesity Association, the American Diabetes Association (ADA) has recruited Novo ...
Novo Nordisk’s Women Are Now Paid More Than the Men, Finans Says
Women employed at Novo Nordisk A/S are now paid more on average than the men working at the maker of blockbuster drugs Wegovy ...
Regeneron's Obesity Trial With Novo Nordisk's Wegovy Hits Lean Target
Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies ...
Zacks Investment Research on MSN3d
Why Novo Nordisk (NVO) is a Top Dividend Stock for Your Portfolio
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent ...